Cargando…
Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Doxorubicin (DOX) constitutes the major constituent of anti-cancer treatment regimens currently in clinical use. However, the precise mechanisms of DOX’s action are not fully understood. Emerging evidence points to the pleiotropic anticancer activity of DOX, including its contribution to DNA damage,...
Autores principales: | Kciuk, Mateusz, Gielecińska, Adrianna, Mujwar, Somdutt, Kołat, Damian, Kałuzińska-Kołat, Żaneta, Celik, Ismail, Kontek, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954613/ https://www.ncbi.nlm.nih.gov/pubmed/36831326 http://dx.doi.org/10.3390/cells12040659 |
Ejemplares similares
-
Substances of Natural Origin in Medicine: Plants vs. Cancer
por: Gielecińska, Adrianna, et al.
Publicado: (2023) -
PD-1/PD-L1 and DNA Damage Response in Cancer
por: Kciuk, Mateusz, et al.
Publicado: (2023) -
Cyclin-Dependent Kinase Synthetic Lethality Partners in DNA Damage Response
por: Kciuk, Mateusz, et al.
Publicado: (2022) -
Synthesis, Computational, and Anticancer In Vitro Investigations of Aminobenzylnaphthols Derived from 2-Naphtol, Benzaldehydes, and α-Aminoacids via the Betti Reaction
por: Kciuk, Mateusz, et al.
Publicado: (2023) -
Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies
por: Kciuk, Mateusz, et al.
Publicado: (2022)